April 27, 2006 by TP Admin
Posted in
The FDA issued an alert reminding healthcare professionals and caregivers that Phenergan (promethazine) is not to be prescribed for children under two years of age. Caution is also advised for older children.
Seven deaths and twenty two cases of significant respiratory depression have occured in children under two.
All forms of promethazine (syrups, suppositories, tablets or injectables) are contraindicated in children less than two years old.
Complete information is available at the US Food and Drug Administration website: FDA ALERT [4/2006]
